KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
Europe - AMS:PHIA - NL0000009538 - Common Stock
23.335 EUR
-0.09 (-0.36%)
We assign a fundamental rating of 3 out of 10 to PHIA. PHIA was compared to 60 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
PHIA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHIA has a Return On Assets of 0.61%. This is in the lower half of the industry: PHIA underperforms 65.00% of its industry peers.
The Return On Equity of PHIA (1.56%) is worse than 65.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.27%, PHIA is in line with its industry, outperforming 43.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROIC | 4.27% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PHIA (0.91%) is worse than 65.00% of its industry peers.
With a Operating Margin value of 6.11%, PHIA perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Operating Margin of PHIA has declined.
Looking at the Gross Margin, with a value of 43.85%, PHIA is doing worse than 73.33% of the companies in the same industry.
PHIA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
PHIA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHIA has more shares outstanding
PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
PHIA has an Altman-Z score of 1.90. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
PHIA has a Altman-Z score of 1.90. This is comparable to the rest of the industry: PHIA outperforms 43.33% of its industry peers.
PHIA has a debt to FCF ratio of 19.41. This is a negative value and a sign of low solvency as PHIA would need 19.41 years to pay back of all of its debts.
PHIA's Debt to FCF ratio of 19.41 is in line compared to the rest of the industry. PHIA outperforms 43.33% of its industry peers.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHIA is outperformed by 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Altman-Z | 1.9 |
ROIC/WACC0.65
WACC6.61%
2.3 Liquidity
A Current Ratio of 1.26 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA has a Current ratio of 1.26. This is in the lower half of the industry: PHIA underperforms 65.00% of its industry peers.
PHIA has a Quick Ratio of 1.26. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, PHIA is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.16%, which is quite good.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -0.81% in the last year.
PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
3.2 Future
The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.65% yearly.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.20 indicates a correct valuation of PHIA.
Based on the Price/Earnings ratio, PHIA is valued cheaper than 86.67% of the companies in the same industry.
PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.47.
A Price/Forward Earnings ratio of 15.25 indicates a correct valuation of PHIA.
PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 71.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.42. PHIA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.2 | ||
| Fwd PE | 15.25 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.77 | ||
| EV/EBITDA | 12.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)68.21
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (11/20/2025, 10:58:54 AM)
23.335
-0.09 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap22.47B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target27.39 (17.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)0.42%
PT rev (3m)1.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.41%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-8.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.2 | ||
| Fwd PE | 15.25 | ||
| P/S | 1.26 | ||
| P/FCF | 51.77 | ||
| P/OCF | 20.45 | ||
| P/B | 2.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.22 |
EPS(TTM)1.44
EY6.17%
EPS(NY)1.53
Fwd EY6.56%
FCF(TTM)0.45
FCFY1.93%
OCF(TTM)1.14
OCFY4.89%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)68.21
PEG (5Y)N/A
Graham Number18.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| ROCE | 5.69% | ||
| ROIC | 4.27% | ||
| ROICexc | 4.72% | ||
| ROICexgc | 15.5% | ||
| OM | 6.11% | ||
| PM (TTM) | 0.91% | ||
| GM | 43.85% | ||
| FCFM | 2.43% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 19.41 | ||
| Debt/EBITDA | 3.01 | ||
| Cap/Depr | 51.35% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 4 | ||
| Cash Conversion | 46.06% | ||
| Profit Quality | 267.9% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.9 |
F-Score8
WACC6.61%
ROIC/WACC0.65
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHIA.AS FAQ
Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.
Can you provide the valuation status for KONINKLIJKE PHILIPS NV?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.
Can you provide the profitability details for KONINKLIJKE PHILIPS NV?
KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.
What is the expected EPS growth for KONINKLIJKE PHILIPS NV (PHIA.AS) stock?
The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 0.24% in the next year.